Characterization of a Sabin-like type 2/3 recombinant poliovirus with a triple nucleotide deletion in the VP1 region isolated from sewage. [PDF]
Lin J +16 more
europepmc +1 more source
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. [PDF]
Mercer LD +14 more
europepmc +1 more source
Acute Transverse Myelitis in a Child Following Oral Live Polio Vaccine Administration. [PDF]
Kramarov S +8 more
europepmc +1 more source
Seroprevalence of Poliovirus Types 1, 2, and 3 Among Children Aged 6-11 Months: Variations Across Survey Rounds in High-Risk Areas of Pakistan. [PDF]
Hussain I +10 more
europepmc +1 more source
Leveraging community insights and navigating logistical challenges: a case study of the 2024 polio vaccination campaign in Gaza, State of Palestine. [PDF]
Dwyer H +23 more
europepmc +1 more source
Current infectious disease management challenges in inborn errors of immunity. [PDF]
Zheng S, Lowe DM.
europepmc +1 more source
Effectiveness of poliovirus environmental surveillance in Ghana: an indicator-based performance evaluation across seven regions, 2018-2022. [PDF]
Obodai E +20 more
europepmc +1 more source
Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread. [PDF]
Candido DDS +15 more
europepmc +1 more source

